North America Chronic Idiopathic Constipation Drug Market Forecast 2017-2025

Publisher Name :
Date: 24-Sep-2017
No. of pages: 68

Key Findings

The North America Chronic Idiopathic Constipation Drug Market is expected to grow at a CAGR of 6.92%. The market value is expected to rise from $1822 million in 2016 to $3358 million by 2025. The changing modern dietary habits, chances of cancer or other systematic disease leading to CIC and the growing increasing elderly population are some of the factors driving the market.

Market Insights

The North America chronic idiopathic constipation drug market is segmented on the basis of drug types and on the basis of the type of prescriptions. The drug type can be further divided into lubiprostone and linaclotide, with the former being a more popular drug. The prescription drug market can be further segmented into over the counter drugs and prescribed drugs. Continuous government initiatives and the already flourishing healthcare and medical industry in countries such as the United States and Canada are benefiting the CIC market growth in this region.

Competitive Insights

Some of the major players in the market include Chugai Pharmaceutical, Allergens, Synergy Pharmaceuticals, Ferring International Center S.A., Pfizer, GlaxoSmithKline, Roche Holding Ag, Merck Sharp & Dohme, Sanofi, Bayer Ag, Eli Lilly And Company, Sucampo Pharmaceuticals Inc, Salix Pharmaceuticals Ltd, Ironwood Pharmaceuticals Inc, Daiichi Sankyo Co Ltd, Valeant Pharmaceuticals International, Cosmo Pharmaceuticals Sa, Theravance Biopharma Inc and Progenics Pharmaceuticals Inc.

North America Chronic Idiopathic Constipation Drug Market Forecast 2017-2025

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study and Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
4. Market Overview
4.1. Market Definition
4.2. Key Market Insights
4.3. Attractive Investment Scenario
4.4. Positioning of Key Cic Drugs Manufacturers In The Market
4.5. Market Drivers
4.5.1. Modern Dietary Habits Taking Toll On The Health
4.5.2. Cancer Or Other Systematic Disease Can Lead To Cic
4.5.3. Increasing Elderly Population
4.5.4. Improved and Efficient Drugs In Pipeline
4.5.5. Increasing Constipation Problems Due To Side Effects of Prescribed Medicines
4.6. Restraints
4.6.1. Surgical Treatments
4.6.2. Unawareness and Ignorance Among People
4.7. Opportunities
4.7.1. High Unmet Needs
4.8. Challenges
4.8.1. Side Effects of Cic Drugs
5. North America Cic Drugs Market, By Drug Type 2017-2025 ($ Million)
5.1. Overview
5.1.1. Lubiprostone
5.1.2. Linaclotide
5.1.3. Others
5.2. Pipeline Drug Analysis: Phase 3: Plecanatide (Year of Launch 2022, $ Million)
5.3. Pipeline Drug Analysis: Phase 3: Elobixibat (Year of Launch 2022, $ Million)
6. North America Cic Drugs Market By Prescription Type 2017-2025 ($ Million)
6.1. Prescribed Drugs
6.2. Over The Counter Drugs
7. Key Analytics
7.1. Porters Five Force Analysis
7.1.1. Intensity of Competitive Rivalry
7.1.2. Bargaining Power of Suppliers
7.1.3. Bargaining Power of Buyers
7.1.4. Threat of Substitute Products
7.1.5. Threat of New Entrants
7.2. Vendor Landscape
7.3. Opportunity Matrix
8. North America Cic Drugs Market By Countries 2017-2025 ($ Million)
8.1. Us
8.2. Canada
9. Company Profiles
9.1. Allergens
9.1.1. Overview
9.1.2. Product Portfolio
9.1.3. Strategic Moves
9.1.4. Scot Analysis
9.2. Chugai Pharmaceutical
9.2.1. Overview
9.2.2. Product Portfolio
9.2.3. Strategic Moves
9.2.4. Scot Analysis
9.3. Ferring International Center S.A.
9.3.1. Overview
9.3.2. Product Portfolio
9.3.3. Scot Analysis
9.4. Synergy Pharmaceuticals
9.4.1. Overview
9.4.2. Product Portfolio
9.4.3. Scot Analysis
9.5. Pfizer
9.5.1. Overview
9.5.2. Pfizer Product Portfolio
9.5.3. Scot Analysis
9.6. Glaxosmithkline
9.6.1. Overview
9.6.2. Product Portfolio
9.6.3. Scot Analysis
9.7. Roche Holding Ag
9.7.1. Overview
9.7.2. Product Portfolio
9.7.3. Strategic Moves
9.7.4. Scot Analysis
9.8. Sanofi
9.8.1. Overview
9.8.2. Product Portfolio
9.8.3. Scot Analysis
9.9. Bayer Ag
9.9.1. Overview
9.9.2. Product Portfolio
9.9.3. Scot Analysis
9.10. Merck Sharp & Dohme
9.10.1. Overview
9.10.2. Product Portfolio
9.10.3. Scot Analysis
9.11. Eli Lilly and Company
9.11.1. Overview
9.11.2. Product Portfolio
9.11.3. Scot Analysis
9.12. Salix Pharmaceuticals Ltd
9.12.1. Overview
9.12.2. Product Portfolio
9.12.3. Scot Analysis
9.13. Sucampo Pharmaceuticals Inc
9.13.1. Overview
9.13.2. Product Portfolio
9.13.3. Scot Analysis
9.14. Ironwood Pharmaceuticals Inc
9.14.1. Overview
9.14.2. Product Portfolio
9.14.3. Scot Analysis
9.15. Valeant Pharmaceuticals International
9.15.1. Overview
9.16. Daiichi Sankyo Co Ltd
9.16.1. Overview
9.16.2. Product Portfolio
9.16.3. Scot Analysis
9.17. Cosmo Pharmaceuticals Sa
9.17.1. Overview
9.17.2. Product Portfolio
9.17.3. Scot Analysis
9.18. Progenics Pharmaceuticals Inc
9.18.1. Overview
9.18.2. Product Portfolio
9.18.3. Scot Analysis
9.19. Theravance Biopharma Inc
9.19.1. Overview
9.19.2. Product Portfolio
9.19.3. Scot Analysis
List of Tables
Table 1 North America Cic Drug Market By Countries 2017-2025 ($ Million)
Table 2 Prominent Drugs and Their Respective Companies In Therapeutics For Chronic Constipation
Table 3 Constipation In Parkinson's Disease
Table 4 Common Medicines Causing Constipation
Table 5 North America Cic Drugs Market By Drug Type 2014-2022($ Million)
Table 6 Product Profile (Lubiprostone)
Table 7 Product Profile (Linaclotide)
Table 8 Product Profile (Bisacodyl)
Table 9 Pipeline Product Profile (Plecanatide)
Table 10 Pipeline Product Profile (Elobixibat)
Table 11 North America Cic Drugs Market By Prescription Type 2017-2025 ($ Million)
Table 12 Linzess Precautions and Side Effects
Table 13 North America Cic Drugs Market By Country 2017-2025 ($ Million)
Table 14 U.S. Cic Drugs Market By Prescription Type 2017-2025 ($ Million)
Table 15 U.S. Cic Drugs Market By Major Drugs 2017-2025 ($ Million)
Table 16 Canada Cic Drugs Market By Prescription Type 2017-2025 ($ Million)
Table 17 Canada Cic Drugs Market By Major Drugs 2017-2025 ($ Million)

List of Figures
Figure 1 North America Chronic Idiopathic Constipation (Cic) Drug Market 2017-2025 ($ Million)
Figure 2 North America Cic Drug Market By Drug Type 2017-2025 ($ Million)
Figure 3 North America Cic Drug Market By Prescription Type In 2016 ($ Million)
Figure 4 Causes of Constipation
Figure 5 Proportion of Population Aged 60 Or Above In 2014
Figure 6 Major Causes of Constipation In Elderly People
Figure 7 Effective Drugs To Create Huge Market Benefits
Figure 8 Surgical Options Available For Constipation
Figure 9 Need of Surgery Process
Figure 10 Common Constipation Drugs and Side Effects Caused Due To Them
Figure 11 North America Lubiprostone Drug Market 2017-2025 ($ Million)
Figure 12 North America Linaclotide Drug Market 2017-2025 ($ Million)
Figure 13 North America Other Drugs Market 2017-2025 ($ Million)
Figure 14 North America Prescribed Cic Drugs Market 2017-2025 ($ Million)
Figure 15 North America Over The Counter Cic Drug Market 2017-2025 ($ Million)
Figure 16 North America Cic Drugs Market 2017-2025 ($ Million)
Figure 17 Us Cic Market, 2017-2025 ($ Million)
Figure 18 Canada Cic Market 2017-2025 ($ Million)
  • 2018-2023 Global Irritable Bowel Syndrome (IBS) Consumption Market Report
    Published: 20-Sep-2018        Price: US 4660 Onwards        Pages: 134
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Irritable Bowel Syndrome (IBS) market for 2018-2023. Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IB......
  • 2015-2023 World Drugs for Traveler's Diarrhea Market Research Report by Product Type, End-User / Application and Regions / Countries
    Published: 12-Sep-2018        Price: US 2800 Onwards        Pages: 97
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Market Segment as follows: By Region / Countries - North America (U.S., Canada, Mexico) - Europe (Germany, U.K., France, Italy, Russia, Spain etc) - South America (Brazil, Argentina etc)......
  • Gastric Ulcers - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 44
    Gastric Ulcers - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Ulcers - Pipeline Review, H2 2018, provides an overview of the Gastric Ulcers (Gastrointestinal) pipeline landscape. Gastric ulcer is a painful sore or ulcer in the lining of stomach. The most common cause of gastric ulcer is Helicobacter pylori bacterial infection. Symptoms include pain, bloating, retching, nausea or......
  • Celiac Disease - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 85
    Celiac Disease - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Celiac Disease - Pipeline Review, H2 2018, provides an overview of the Celiac Disease (Gastrointestinal) pipeline landscape. Celiac disease is an autoimmune disorder caused by an immune response to wheat protein gluten. Symptoms include weight loss, vomiting, abdominal bloating, abdominal pain and persistent diarrhea. Risk fa......
  • Pancreatitis - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 87
    Pancreatitis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatitis - Pipeline Review, H2 2018, provides an overview of the Pancreatitis (Gastrointestinal) pipeline landscape. Pancreatitis is an inflammation of pancreas. Symptoms include upper abdominal pain, nausea, vomiting, and tenderness when touching the abdomen, weight loss and upper abdominal pain. Predisposing factors inclu......
  • Alcoholic Hepatitis - Pipeline Review, H2 2018
    Published: 11-Sep-2018        Price: US 2000 Onwards        Pages: 76
    Alcoholic Hepatitis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alcoholic Hepatitis - Pipeline Review, H2 2018, provides an overview of the Alcoholic Hepatitis (Gastrointestinal) pipeline landscape. Alcoholic hepatitis is an inflammation of the liver. It is typically caused by excessive alcohol consumption over a long period of time. Symptoms include changes in appetite, dry mouth, w......
  • Global Gastrointestinal OTC Drugs Market Insights, Forecast to 2025
    Published: 07-Sep-2018        Price: US 3900 Onwards        Pages: 124
    This report studies the global market size of Gastrointestinal OTC Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Gastrointestinal OTC Drugs in these regions. This research report categorizes the global Gastrointestinal OTC Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future tre......
  • Digital Landscape: Inflammatory Bowel Disease
    Published: 06-Sep-2018        Price: US 6000 Onwards        Pages: 159
    Digital Landscape: Inflammatory Bowel Disease Summary The Digital Landscape Inflammatory Bowel Disease report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn's disease and ulcerative colitis (UC). Key Highlights - US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen......
  • Global Inflammatory Bowel Disease Partnering 2012 to 2018
    Published: 01-Sep-2018        Price: US 1995 Onwards        Pages: 100
    "Delivery of this report will take 1-3 days after purchase." The Global Inflammatory Bowel Disease Partnering Terms and Agreements since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs